tiprankstipranks
Trending News
More News >
Tauns Laboratories, Inc. (JP:197A)
:197A
Japanese Market
Advertisement

Tauns Laboratories, Inc. (197A) Income Statement

Compare
0 Followers

Tauns Laboratories, Inc. Income Statement

Last quarter (Q3 2025), Tauns Laboratories, Inc.'s total revenue was ¥5.63B, an increase of 1.18% from previous quarter. In Q3, Tauns Laboratories, Inc.'s net income was ¥1.96B. See Tauns Laboratories, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
¥ 18.63B¥ 18.43B¥ 15.67B¥ 17.46B
Gross Profit
¥ 12.33B¥ 12.50B¥ 8.79B¥ 14.29B
Operating Expenses
¥ 4.06B¥ 4.47B¥ 3.82B¥ 3.10B
Depreciation and Amortization
¥ 715.43M¥ 676.16M¥ 639.97M¥ 567.24M
EBITDA
¥ 9.02B¥ 8.65B¥ 5.32B¥ 8.55B
Operating Income
¥ 8.27B¥ 8.03B¥ 4.97B¥ 11.19B
Other Income/Expenses
¥ -63.15M¥ -195.40M¥ -312.42M¥ -3.21B
Pretax Income
¥ 8.20B¥ 7.83B¥ 4.65B¥ 7.98B
Net Income
¥ 6.32B¥ 5.77B¥ 3.03B¥ 4.48B
Per Share Metrics
Basic EPS
¥ 62.07¥ 57.74¥ 30.35¥ 44.81
Diluted EPS
¥ 58.90¥ 57.74¥ 30.35¥ 44.81
Weighted Average Shares Outstanding
101.74M 106.95M 100.00M 100.00M
Weighted Average Shares Outstanding (Diluted)
107.22M 100.00M 100.00M 100.00M
Currency in JPY

Tauns Laboratories, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis